December 19, 2022
National and local media outlets highlighted the partnership between the University of Cincinnati's Dan Arendt and Cincinnati nonprofit Caracole, who have installed a harm reduction vending machine that helps prevent overdoses in Hamilton County.
December 20, 2022
The University of Cincinnati's Alberto Espay joined 55KRC's Simply Medicine program to discuss stiff person syndrome following singer Céline Dion's announcement she has been diagnosed with the neurological condition.
December 22, 2022
The University of Cincinnati's Christopher Richards, MD, co-authored an accompanying editorial to new research that showed high variability in the way EMS agencies document stroke cases, which was recently featured by MedPage Today.
January 3, 2023
The University of Cincinnati's Eva Mistry is leading a new study with funding support from the Patient-Centered Outcomes Research Institute that will examine the effectiveness of a stroke treatment for patients with a pre-stroke disability, one of the first studies to focus on this population.
January 3, 2023
The University of Cincinnati's Caroline Billingsley, MD, was featured in a Q&A article on OncLive discussing the use of antibody-drug conjugates in ovarian cancer treatment.
January 3, 2023
The University of Cincinnati's LaTrice Montgomery was featured in a recent WHAS news report on Kentucky's new medical marijuana executive order.
January 9, 2023
The University of Cincinnati's Carla F. Justiniano, MD, joined 55KRC's Simply Medicine to discuss colon cancer screening and prevention following the death of actor Kirstie Alley.
January 10, 2023
Krushna Patra is the first University of Cincinnati researcher to receive the prestigious National Cancer Institute MERIT Award to continue his research on how mutations help pancreatic cancer grow.
January 10, 2023
Parkinson's News Today highlighted results of a recent trial, led in the U.S. by the University of Cincinnati's Alberto Espay, that found a liquid drug formulation was more effective than an oral formulation to control symptoms of Parkinson's disease.
January 11, 2023
The University of Cincinnati's Alberto Espay, MD, spoke with NBC News about the impact of the cost of newly approved Alzheimer's drug Leqembi.